Justera Health Ltd.
VTAL
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -9.21% | 745.59% | -45.39% | -86.70% | -84.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -9.21% | 745.59% | -45.39% | -86.70% | -84.02% |
| Cost of Revenue | 53.85% | 268.56% | -75.79% | -93.82% | -95.98% |
| Gross Profit | -33.24% | 2,054.13% | 95.77% | -76.17% | 218.74% |
| SG&A Expenses | 51.22% | -54.43% | -42.82% | 414.46% | -23.98% |
| Depreciation & Amortization | -74.31% | -70.60% | -70.18% | -96.17% | -9.80% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.39% | -42.66% | -58.32% | -41.76% | -70.12% |
| Operating Income | -63.20% | 92.19% | 71.32% | -205.10% | 50.17% |
| Income Before Tax | -219.30% | 96.55% | 86.55% | 62.75% | 47.08% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -219.30% | 96.55% | 86.55% | 73.44% | 47.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -219.30% | 96.55% | 86.55% | 73.44% | 47.08% |
| EBIT | -63.20% | 92.19% | 71.32% | -205.10% | 50.17% |
| EBITDA | -84.34% | 94.34% | 70.05% | -193.54% | 53.25% |
| EPS Basic | -141.79% | 98.18% | 89.47% | 80.77% | 56.21% |
| Normalized Basic EPS | -23.08% | 94.12% | 80.56% | -171.43% | 59.38% |
| EPS Diluted | -141.79% | 98.18% | 89.47% | 80.77% | 56.21% |
| Normalized Diluted EPS | -23.08% | 94.12% | 80.56% | -171.43% | 59.38% |
| Average Basic Shares Outstanding | 32.10% | 35.39% | 35.39% | 47.14% | 21.16% |
| Average Diluted Shares Outstanding | 32.10% | 35.39% | 35.39% | 47.14% | 21.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
